-
1دورية أكاديمية
المؤلفون: Glaviano, Antonino, Foo, Aaron, Lam, Hiu, Yap, Kenneth, Jacot, William, Jones, Robert, Eng, Huiyan, Nair, Madhumathy, Makvandi, Pooyan, Geoerger, Birgit, Kulke, Matthew, Baird, Richard, Prabhu, Jyothi, Carbone, Daniela, Pecoraro, Camilla, Teh, Daniel, Sethi, Gautam, Cavalieri, Vincenzo, Lin, Kevin, Javidi-Sharifi, Nathalie, Toska, Eneda, Davids, Matthew, Brown, Jennifer, Diana, Patrizia, Stebbing, Justin, Kumar, Alan, Fruman, David
المصدر: Molecular Cancer. 22(1)
مصطلحات موضوعية: AKT inhibitors, ATP-competitive mTOR inhibitors, Allosteric mTOR inhibitors, Bi-steric mTOR inhibitors, Cancer, Dual PI3K/mTOR inhibitors, Isoform-specific PI3K inhibitors, PDK1 inhibitors, PI3K/AKT/mTORC pathway, Pan PI3K inhibitors, Humans, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Signal Transduction, TOR Serine-Threonine Kinases, Neoplasms
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/3x80g7hpTest
-
2دورية أكاديمية
المؤلفون: Eunüs S. Ali, Kangkana Mitra, Shamima Akter, Sarker Ramproshad, Banani Mondal, Ishaq Khan, Muhammad Torequl Islam, Javad Sharifi‐Rad, Daniela Călina, William C. Cho
مصطلحات موضوعية: mTOR Signaling in Growth and Disease, Molecular Biology, Biochemistry, Genetics and Molecular Biology, Life Sciences, Role of Pim Oncogenes in Tumorigenesis, Pathology and Forensic Medicine, Medicine, Health Sciences, Polyamines and Biogenic Amines in Biology and Health, PI3K/AKT pathway, mTOR, Cancer, rapamycin, PI3K/AKT/mTOR pathway, Autophagy, Sirolimus, Cancer research, Protein kinase B, Discovery and development of mTOR inhibitors, RPTOR, Mechanistic target of rapamycin, Signal transduction, Bioinformatics, FOS Computer and information sciences, Pharmacology, Biology, Computational biology, Apoptosis, Cell biology, Internal medicine
-
3
المؤلفون: Seyed Mohammad Abedi, Samaneh Vaseghi, Nasrin Abbasi Gharibkandi, Alireza Mardanshahi, Sajjad Molavipordanjani
المصدر: Molecular Biology Reports. 48:1-14
مصطلحات موضوعية: Cell Survival, medicine.medical_treatment, Apoptosis, Radiation Tolerance, Phosphatidylinositol 3-Kinases, Cell Line, Tumor, Neoplasms, Autophagy, Genetics, medicine, Humans, Radiosensitivity, Protein Kinase Inhibitors, Molecular Biology, Protein kinase B, PI3K/AKT/mTOR pathway, Cell Proliferation, Phosphoinositide-3 Kinase Inhibitors, Cell growth, Akt/PKB signaling pathway, business.industry, TOR Serine-Threonine Kinases, Cell Cycle, Cancer, MTOR Inhibitors, General Medicine, medicine.disease, Radiation therapy, Cancer research, business, Proto-Oncogene Proteins c-akt, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18fdb87979d16875fbb742eee534b74bTest
https://doi.org/10.1007/s11033-021-06607-3Test -
4
المؤلفون: Jun Sang, Sheng Yin, Ming-Feng Zou, Jia-Luo Huang, Zi-Jun Lin, Gui-Hua Tang, Lu Gan, Wei Li, Run-Zhu Fan
المصدر: Cancer letters. 526
مصطلحات موضوعية: MAPK/ERK pathway, Male, Cancer Research, Transfection, Paraptosis, Mice, Cell Line, Tumor, medicine, Autophagy, Animals, Humans, Protein kinase B, Bladder cancer, Everolimus, Chemistry, Cancer, MTOR Inhibitors, medicine.disease, Temsirolimus, Oncology, Urinary Bladder Neoplasms, Cancer research, Diterpenes, Proto-Oncogene Proteins c-akt, medicine.drug, Drugs, Chinese Herbal, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a31b0bbf74b43754d9a2d99aa3ad41bTest
https://pubmed.ncbi.nlm.nih.gov/34798195Test -
5مراجعة
المؤلفون: Glaviano, A, Foo, ASC, Lam, HY, Yap, KCH, Jacot, W, Jones, RH, Eng, H, Nair, MG, Makvandi, P, Geoerger, B, Kulke, MH, Baird, RD, Prabhu, JS, Carbone, D, Pecoraro, C, Teh, DBL, Sethi, G, Cavalieri, V, Lin, KH, Javidi-Sharifi, NR, Toska, E, Davids, MS, Brown, JR, Diana, P, Stebbing, J, Fruman, DA, Kumar, AP
المساهمون: CANCER SCIENCE INSTITUTE OF SINGAPORE, MICROBIOLOGY AND IMMUNOLOGY, PHARMACOLOGY, PHYSIOLOGY
المصدر: Elements
مصطلحات موضوعية: AKT inhibitors, ATP-competitive mTOR inhibitors, Allosteric mTOR inhibitors, Bi-steric mTOR inhibitors, Cancer, Dual PI3K/mTOR inhibitors, Isoform-specific PI3K inhibitors, PDK1 inhibitors, PI3K/AKT/mTORC pathway, Pan PI3K inhibitors, Humans, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Signal Transduction, TOR Serine-Threonine Kinases, Neoplasms
العلاقة: Glaviano, A, Foo, ASC, Lam, HY, Yap, KCH, Jacot, W, Jones, RH, Eng, H, Nair, MG, Makvandi, P, Geoerger, B, Kulke, MH, Baird, RD, Prabhu, JS, Carbone, D, Pecoraro, C, Teh, DBL, Sethi, G, Cavalieri, V, Lin, KH, Javidi-Sharifi, NR, Toska, E, Davids, MS, Brown, JR, Diana, P, Stebbing, J, Fruman, DA, Kumar, AP (2023-12-01). PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Molecular Cancer 22 (1) : 138-. ScholarBank@NUS Repository. https://doi.org/10.1186/s12943-023-01827-6Test; https://scholarbank.nus.edu.sg/handle/10635/245930Test
-
6
المؤلفون: Malihe Hasanzadeh, Amir Avan, Gordon A. Ferns, Seyed Mahdi Hassanian, Afsane Bahrami, Majid Khazaei, Soodabeh Shahidsales, Mina Maftouh
المصدر: Journal of Cellular Biochemistry. 119:213-222
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Antineoplastic Agents, Breast Neoplasms, Pharmacology, Biochemistry, Phosphatidylinositol 3-Kinases, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Internal medicine, medicine, Humans, In patient, Protein Kinase Inhibitors, Molecular Biology, Protein kinase B, PI3K/AKT/mTOR pathway, Phosphoinositide-3 Kinase Inhibitors, Everolimus, Cell growth, business.industry, TOR Serine-Threonine Kinases, Cancer, Cell Biology, medicine.disease, Discovery and development of mTOR inhibitors, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, business, Proto-Oncogene Proteins c-akt, Signal Transduction, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cceefbc6d1dcc5e783a4b2209a88d841Test
https://doi.org/10.1002/jcb.26136Test -
7
المؤلفون: N. Leonard, Siobhan Nicholson, Sinead Cuffe, Stephen P. Finn, Kathy Gately, Ronan Ryan, Martin P. Barr, Susan Heavey, Niall McVeigh, Kenneth J. O'Byrne, Vincent Young
المصدر: Oncotarget
مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Veterinary medicine, Lung Neoplasms, DNA Mutational Analysis, Apoptosis, NSCLC, PI3K, 0302 clinical medicine, Piperidines, Carcinoma, Non-Small-Cell Lung, Clinical investigation, Antineoplastic Combined Chemotherapy Protocols, Medicine, Molecular Targeted Therapy, Sulfonamides, TOR Serine-Threonine Kinases, MEK inhibitor, High mortality, Drug Synergism, co-target, Middle Aged, MAP Kinase Kinase Kinases, Discovery and development of mTOR inhibitors, MEK, Gene Expression Regulation, Neoplastic, 030220 oncology & carcinogenesis, Female, Research Paper, Signal Transduction, medicine.medical_specialty, Indazoles, Class I Phosphatidylinositol 3-Kinases, Translational research, Gene Expression Regulation, Enzymologic, lung, 03 medical and health sciences, Internal medicine, Humans, Protein Kinase Inhibitors, PI3K/AKT/mTOR pathway, Aged, Cell Proliferation, Dose-Response Relationship, Drug, business.industry, Cancer, medicine.disease, respiratory tract diseases, Clinical trial, 030104 developmental biology, A549 Cells, Mutation, Azetidines, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce4a84adaa2966ee301712af6eea68d5Test
https://doi.org/10.18632/oncotarget.12755Test -
8
المؤلفون: Ji Nie, Xuelei Ma, Jing Yang, Xiawei Wei, Yong Peng, Yuquan Wei
المصدر: Molecular Cancer
Molecular Cancer, Vol 18, Iss 1, Pp 1-28 (2019)مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Antineoplastic Agents, Review, Biology, lcsh:RC254-282, PI3K signaling, PI3K, Target therapy, 03 medical and health sciences, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, Neoplasms, medicine, Animals, Humans, Molecular Targeted Therapy, Protein kinase B, Protein Kinase Inhibitors, PI3K/AKT/mTOR pathway, Cancer, Phosphoinositide-3 Kinase Inhibitors, Clinical Trials as Topic, TOR Serine-Threonine Kinases, Master regulator, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Discovery and development of mTOR inhibitors, Clinical trial, Gene Expression Regulation, Neoplastic, 030104 developmental biology, Oncology, Tumor progression, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cancer research, mTOR, Molecular Medicine, Proto-Oncogene Proteins c-akt, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::760fbcdfb07da0c9e7201f544add6b61Test
http://europepmc.org/articles/PMC6379961Test -
9
المؤلفون: Eugene Kim, Estela Jacinto, Cedric Magaway
المصدر: Cells
مصطلحات موضوعية: mTOR inhibitors, rapalogs, cancer metabolism, Metabolic network, Antineoplastic Agents, Review, mTORC1, Biology, medicine.disease_cause, mTORC2, Phosphatidylinositol 3-Kinases, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, medicine, kinase inhibitors, Humans, Molecular Targeted Therapy, Protein Kinase Inhibitors, PI3K/AKT/mTOR pathway, 030304 developmental biology, 0303 health sciences, mTOR in immunotherapy, TOR Serine-Threonine Kinases, Cancer, General Medicine, medicine.disease, 3. Good health, 030220 oncology & carcinogenesis, Cancer cell, mTOR signaling, Cancer research, Energy Metabolism, Carcinogenesis, metabolism, nutrient metabolism, Flux (metabolism), Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d6cf135799d6af945b273b51334fa46Test
https://doi.org/10.3390/cells8121584Test -
10
المؤلفون: J. W. de Fijter, M. Reinwald, Nicolas J. Mueller, Paolo Grossi, Mario Fernández-Ruiz, José Tiago Silva, J. Fortún, Christian Garzoni, José María Aguado
المساهمون: University of Zurich, Reinwald, M
المصدر: Clinical Microbiology and Infection, 24, S53-S70
Clinical Microbiology and Infectionمصطلحات موضوعية: Microbiology (medical), mTOR inhibitors, 610 Medicine & health, Communicable Diseases, 2726 Microbiology (medical), 10234 Clinic for Infectious Diseases, Idelalisib, Immunocompromised Host, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, BCR-ABL kinase inhibitors, Humans, Medicine, Bruton's tyrosine kinase, 030212 general & internal medicine, Protein Kinase Inhibitors, Clinical Trials as Topic, Janus kinase inhibitors, biology, business.industry, Venetoclax, TOR Serine-Threonine Kinases, Ibrutinib, Cancer, 2725 Infectious Diseases, General Medicine, Protein-Tyrosine Kinases, medicine.disease, Small-molecule inhibitors, Biological Therapy, Dasatinib, Infectious Diseases, chemistry, 030220 oncology & carcinogenesis, Immunology, biology.protein, Janus kinase, business, Infection, Tyrosine kinase, Signal Transduction, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::448f16e47368750357811b7ea91f6617Test
http://hdl.handle.net/1887/86607Test